The Tralokinumab Biosimilar Anti-IL13 Antibody is a cutting-edge research tool designed for studying the interleukin-13 (IL-13) signaling pathway. This monoclonal antibody, engineered specifically for targeting IL-13, has been rigorously validated for use in a variety of applications, including ELISA, immunofluorescence, and flow cytometry.IL-13 is a key cytokine involved in allergic inflammation and immune responses. By blocking IL-13, researchers can gain insights into the mechanisms underlying allergic diseases such as asthma, atopic dermatitis, and allergic rhinitis. Additionally, IL-13 has been implicated in the pathogenesis of certain cancers and inflammatory conditions, making this antibody an invaluable tool for investigating these disease processes.
With its high specificity and affinity for IL-13, the Tralokinumab Biosimilar Anti-IL13 Antibody offers researchers a reliable means of studying the IL-13 pathway and exploring its potential as a therapeutic target. Whether investigating basic mechanisms of immune regulation or developing novel treatments for IL-13-related disorders, this antibody is an essential tool for advancing biomedical research.
Product Name:
Tralokinumab (Anti-IL13) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0129
Target:
IL13
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
CAT-354, tralokinumab-idrm
Description:
Anti-IL13(tralokinumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG4
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
